Vitruvias is a specialty generic pharmaceutical business focused on the development and marketing of generic products with either (i) complex APIs that are difficult to source, or (ii) finished dosage forms that are inherently difficult to manufacture. The highly skilled team at Vitruvias has expertise in all aspects of the pharmaceutical industry, including product development, licensing, regulatory affairs, marketing, financial analysis, distribution, managed care, trade relations and sales.
vitruvias.com.
Location: United States, Alabama, Auburn
Total raised: $11.5M
Investors 1
| Date | Name | Website |
| - | Perceptive... | perceptive... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 09.01.2018 | Series A | $11.5M | Perceptive... |
Mentions in press and media 4
| Date | Title | Description | Source |
| 09.01.2018 | Term Sheet — Tuesday, January 9 | A DYNAMITE YEAR Good morning, Term Sheet readers. Paid Content You can't secure what you can't see... | fortune.co... |
| 09.01.2018 | Vitruvias Therapeutics Completes $11.5M Series A Financing | Vitruvias Therapeutics, Inc., an Auburn, Ala.-based generic pharmaceutical company with a focus on s... | finsmes.co... |
| 07.01.2018 | Vitruvias Therapeutics Completes $11.5M Series A Led by JW A... | AUBURN, Ala.--(BUSINESS WIRE)--Vitruvias Therapeutics Inc., a private generic pharmaceutical company... | archive.ci... |
| 07.01.2018 | Vitruvias Therapeutics Completes $11.5M Series A Led by JW A... | AUBURN, Ala.--(BUSINESS WIRE)--Vitruvias Therapeutics Inc., a private generic pharmaceutical company... | citybizlis... |